Optic neuropathy due to microbead-induced elevated intraocular pressure in the mouse

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 1, 2011, Pages 36-44

  Chen, Huihui ^a,b,c   Wei, Xin ^b,c,d   Cho, Kin Sang ^b   Chen, Guochun ^a,b   Sappington, Rebecca ^d   Calkins, David J ^d   Chen, Dong F ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^c SICHUAN UNIVERSITY   (China)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLYSTYRENE; MICROSPHERE; POLYSTYRENE DERIVATIVE; TUBB3 PROTEIN, MOUSE; TUBULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTERIOR EYE CHAMBER; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DISEASE MODEL; ELECTRON MICROSCOPY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INTRAOCULAR HYPERTENSION; MOUSE; NERVE FIBER DEGENERATION; NONHUMAN; OPTIC NERVE DISEASE; PARTICLE SIZE; PRIORITY JOURNAL; RETINA GANGLION CELL; TONOMETRY; ANIMAL; C57BL MOUSE; FLUORESCENCE MICROSCOPY; INJECTION; INTRAOCULAR PRESSURE; METABOLISM; NERVE FIBER; OCULOPLETHYSMOGRAPHY; PATHOLOGY; TIME; ULTRASTRUCTURE;

ANIMALS; ANTERIOR CHAMBER; AXONS; DISEASE MODELS, ANIMAL; INJECTIONS; INTRAOCULAR PRESSURE; MICE; MICE, INBRED C57BL; MICROSCOPY, FLUORESCENCE; MICROSPHERES; OCULAR HYPERTENSION; OPTIC NERVE DISEASES; POLYSTYRENES; RETINAL GANGLION CELLS; TIME FACTORS; TONOMETRY, OCULAR; TUBULIN;

EID: 79952238681     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-5115     Document Type: Article

References (44)

1. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90:262-267.
2. Quigley HA, Reacher M, Katz J, Strahlman E, Gilbert D, Scott R. Quantitative grading of nerve fiber layer photographs. Ophthalmology. 1993;100:1800-1807.
3. Foster PJ. The epidemiology of primary angle closure and associated glaucomatous optic neuropathy. Semin Ophthalmol. 2002; 17:50-58.
4. Singh K, Shrivastava A. Intraocular pressure fluctuations: how much do they matter? Curr Opin Ophthalmol. 2009;20:84-87.
5. Varma R, Peeples P, Walt JG, Bramley TJ. Disease progression and the need for neuroprotection in glaucoma management. Am J Manag Care. 2008;14(suppl):S15-S19.
6. Lindsey JD, Weinreb RN. Elevated intraocular pressure and trans-genic applications in the mouse. J Glaucoma. 2005;14:318-320.
7. John SW. Mechanistic insights into glaucoma provided by experimental genetics the Cogan lecture. Invest Ophthalmol Vis Sci. 2005;46:2649-2661.
8. John SW, Smith RS, Savinova OV, et al. Essential iris atrophy, pigment dispersion, and glaucoma in DBA/2J mice. Invest Oph-thalmol Vis Sci. 1998;39:951-962.
9. Chang B, Smith RS, Hawes NL, et al. Interacting loci cause severe iris atrophy and glaucoma in DBA/2J mice. Nat Genet. 1999;21: 405-409.
10. Schlamp CL, Li Y, Dietz JA, Janssen KT, Nickells RW. Progressive ganglion cell loss and optic nerve degeneration in DBA/2J mice is variable and asymmetric. BMC Neurosci. 2006;7:66.
11. Pang IH, Clark AF. Rodent models for glaucoma retinopathy and optic neuropathy. J Glaucoma. 2007;16:483-505.
12. Gelatt KN, Brooks DE, Samuelson DA. Comparative glaucomatol-ogy, II: The experimental glaucomas. J Glaucoma. 1998;7:282-294.
13. WoldeMussie E, Ruiz G, Wijono M, Wheeler LA. Neuroprotection of retinal ganglion cells by brimonidine in rats with laser-induced chronic ocular hypertension. Invest Ophthalmol Vis Sci. 2001;42: 2849-2855.
14. Aihara M, Lindsey JD, Weinreb RN. Experimental mouse ocular hypertension: establishment of the model. Invest Ophthalmol Vis Sci. 2003;44:4314-4320.
15. Morrison JC, Moore CG, Deppmeier LM, Gold BG, Meshul CK, Johnson EC. A rat model of chronic pressure-induced optic nerve damage. Exp Eye Res. 1997;64:85-96.
16. Sappington RM, Carlson BJ, Crish SD, Calkins DJ. The microbead occlusion model: a paradigm for induced ocular hypertension in rats and mice. Invest Ophthalmol Vis Sci. 2010;51:207-216.
17. Saeki T, Aihara M, Ohashi M, Araie M. The efficacy of TonoLab in detecting physiological and pharmacological changes of mouse intraocular pressure-comparison with TonoPen and microneedle manometery. Curr Eye Res. 2008;33:247-252.
18. Cho KS, Yang L, Lu B, et al. Re-establishing the regenerative potential of central nervous system axons in postnatal mice. J Cell Sci. 2005;118:863-872.
19. Li RS, Chen BY, Tay DK, Chan HH, Pu ML, So KF. Melanopsin-expressing retinal ganglion cells are more injury-resistant in a chronic ocular hypertension model. Invest Ophthalmol Vis Sci. 2006;47:2951-2958.
20. Yang H, Hirooka K, Fukuda K, Shiraga F. Neuroprotective effects of angiotensin II type 1 receptor blocker in a rat model of chronic glaucoma. Invest Ophthalmol Vis Sci. 2009;50:5800-5804.
21. Huang W, Hui Y, Zhang M. Retrograde labeling of adult rat retinal ganglion cells with the fluorogold. Yan Ke Xue Bao. 2000;16:29-33.
22. Chiu K, Lau WM, Yeung SC, Chang RC, So KF. Retrograde labeling of retinal ganglion cells by application of fluoro-gold on the surface of superior colliculus. J Vis Exp. Jun 17;(16). pii: 819. doi 10.3791/ 819.
23. Quigley HA, McKinnon SJ, Zack DJ, et al. Retrograde axonal transport of BDNF in retinal ganglion cells is blocked by acute IOP elevation in rats. Invest Ophthalmol Vis Sci. 2000;41:3460-3466.
24. Koprivica V, Cho KS, Park JB, et al. EGFR activation mediates inhibition of axon regeneration by myelin and chondroitin sulfate proteoglycans. Science. 2005;310:106-110.
25. Fournier AE, McKerracher L. Tubulin expression and axonal transport in injured and regenerating neurons in the adult mammalian central nervous system. Biochem Cell Biol. 1995;73:659-664.
26. Fitzgerald M, Bartlett CA, Evill L, Rodger J, Harvey AR, Dunlop SA. Secondary degeneration of the optic nerve following partial transection: the benefits of lomerizine. Exp Neurol. 2009;216: 219-230.
27. Sharma RK, Netland PA. Early born lineage of retinal neurons express class III beta-tubulin isotype. Brain Res. 2007;1176:11-17.
28. Hu Y, Cui Q, Harvey AR. Interactive effects of C3, cyclic AMP and ciliary neurotrophic factor on adult retinal ganglion cell survival and axonal regeneration. Mol Cell Neurosci. 2007;34:88-98.
29. Smith PD, Sun F, Park KK, et al. SOCS3 deletion promotes optic nerve regeneration in vivo. Neuron. 2009;64:617-623.
30. Mellough CB, Cui Q, Spalding KL, et al. Fate of multipotent neural precursor cells transplanted into mouse retina selectively depleted of retinal ganglion cells. Exp Neurol. 2004;186:6-19.
31. Pimentel B, Sanz C, Varela-Nieto I, Rapp UR, De Pablo F, de la Rosa EJ. c-Raf regulates cell survival and retinal ganglion cell morphogenesis during neurogenesis. J Neurosci. 2000;20:3254-3262.
32. Cui Q, Yip HK, Zhao RCH, So K-F, Harvey AR. Intraocular elevation of cyclic AMP potentiates ciliary neurotrophic factor-induced regeneration of adult rat retinal ganglion cell axons. Mol Cell Neu-rosci. 2003;22:49-61.
33. Portillo JA, Okenka G, Kern TS, Subauste CS. Identification of primary retinal cells and ex vivo detection of proinflammatory molecules using flow cytometry. Mol Vis. 2009;15:1383-1389.
34. Seamone C, LeBlanc R, Rubillowicz M, Mann C, Orr A. The value of indices in the central and peripheral visual fields for the detection of glaucoma. Am J Ophthalmol. 1988;106:180-185.
35. Stewart WC, Shields MB. The peripheral visual field in glaucoma: reevaluation in the age of automated perimetry. Surv Ophthalmol. 1991;36:59-69.
36. Jakobs TC, Libby RT, Ben Y, et al. Retinal ganglion cell degeneration is topological but not cell type specific in DBA/2J mice. J Cell Biol. 2005;171:313-325.
37. Fitzgerald M, Payne SC, Bartlett CA, Evill L, Harvey AR, Dunlop SA. Secondary retinal ganglion cell death and the neuroprotective effects of the calcium channel blocker, lomerizine. Invest Oph-thalmol Vis Sci. 2009;50:5456-5462.
38. Danias J, Lee KC, Zamora MF, et al. Quantitative analysis of retinal ganglion cell (RGC) loss in aging DBA/2NNia glaucomatous mice: comparison with RGC loss in aging C57/BL6 mice. Invest Ophthal-mol Vis Sci. 2003;44:5151-5162.
39. Strom RC, Williams RW. Cell production and cell death in the generation of variation in neuron number. J Neurosci. 1998;18: 9948-9953.
40. McKinnon SJ, Schlamp CL, Nickells RW. Mouse models of retinal ganglion cell death and glaucoma. Exp Eye Res. 2009;88:816-824.
41. Steele MR, Inman DM, Calkins DJ, Horner PJ, Vetter ML. Microar-ray analysis of retinal gene expression in the DBA/2J model of glaucoma. Invest Ophthalmol Vis Sci. 2006;47:977-985.
42. Buckingham BP, Inman DM, Lambert W, et al. Progressive ganglion cell degeneration precedes neuronal loss in a mouse model of glaucoma. J Neurosci. 2008;28:2735-2744.
43. Surgucheva I, Weisman AD, Goldberg JL, Shnyra A, Surguchov A. Gamma-synuclein as a marker of retinal ganglion cells. Mol Vis. 2008;14:1540-1548.
44. Laquis S, Chaudhary P, Sharma SC. The patterns of retinal ganglion cell death in hypertensive eyes. Brain Res. 1998;784:100-104.